CRT PIONEER FUND, BACIT AND SAREUM ENTER AGREEMENT TO FUND DEVELOPMENT OF DRUGS TO TREAT CANCERS INCLUDING PANCREATIC, BOWEL AND LUNGCo-Funding Agreement • September 24th, 2013
Contract Type FiledSeptember 24th, 2013THE Cancer Research Technology Pioneer Fund (CPF), London Stock Exchange-‐listed investment company, BACIT Limited (BACIT), and drug discovery company, Sareum Limited (Sareum), have entered into an agreement to co-‐fund the further development of a class of cancer drugs called CHK1 inhibitors.